Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article The Psychedelic News Feed: Oct 9 – Nov 5, 2023

The Psychedelic News Feed: Oct 9 – Nov 5, 2023

  • Post published:November 6, 2023
  • Post category:Psychedelic News Feed Archive
Read more about the article Psychedelic Bulletin #148 (Pα+)

Psychedelic Bulletin #148 (Pα+)

  • Post published:November 3, 2023
  • Post category:Psychedelic Bulletin/Pα+
Read more about the article Introducing Pα+

Introducing Pα+

  • Post published:November 1, 2023
  • Post category:Announcements
Read more about the article Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

  • Post published:October 31, 2023
  • Post category:Analysis/News
Read more about the article Colorado DOR Natural Medicine Division Listening Sessions: Part 1

Colorado DOR Natural Medicine Division Listening Sessions: Part 1

  • Post published:October 24, 2023
  • Post category:Colorado Natural Medicine Advisory Bulletin
Read more about the article Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more

Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more

  • Post published:October 17, 2023
  • Post category:Psychedelic Bulletin
Read more about the article Natural Medicine Advisory Bulletin #4: September 2023

Natural Medicine Advisory Bulletin #4: September 2023

  • Post published:October 11, 2023
  • Post category:Colorado Natural Medicine Advisory Bulletin
Read more about the article Introducing the Psychedelic News Feed

Introducing the Psychedelic News Feed

  • Post published:October 10, 2023
  • Post category:News
Read more about the article atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

  • Post published:October 6, 2023
  • Post category:Press Release
Read more about the article Reunion Neuroscience Inc. to Participate in October Investor Conferences

Reunion Neuroscience Inc. to Participate in October Investor Conferences

  • Post published:October 5, 2023
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More